Coronavirus Update

FDA Authorizes First Covid-19 and Flu Combination Test for Use with Home-Collected Samples

The U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both Covid-19 and influenza A and B (flu).

The FDA authorized Quest Diagnostics RC Covid-19 +Flu RT-PCR Test for prescription use with the Quest Diagnostics Self-Collection Kit for Covid-19 +Flu by individuals who are suspected of respiratory viral infection consistent with Covid-19 when home collection is determined to be appropriate by an individual’s healthcare provider. Under a health care provider’s order, patients can collect a sample at home and ship it to a Quest Diagnostics laboratory for analysis following the instructions included with the self-collection kit.

More details on the FDA website.

06.12.2020

News • Environmental impact

Plastic waste from test kits: call for urgent action

During the Covid-19 pandemic, everyone became familiar with lateral flow tests. These tests generate a lot of plastic waste, creating an environmental crisis. Experts call for urgent action.

News • Based on image-based flow cytometry

Rapid test to predict severe Covid-19 infections

Researchers have developed a method for assessing the number and structure of aggregated blood platelets (or thrombocytes) that can potentially help quantify the risk of a severe Covid-19 infection.…

News • Using AI nanopores

New rapid testing method for Covid-19

Researchers from Osaka University present a novel technique to detect different coronavirus variants quickly, including fast-spreading strains present in human saliva.